BIANCONI, FORTUNATO
 Distribuzione geografica
Continente #
NA - Nord America 3.462
EU - Europa 2.587
AS - Asia 2.260
SA - Sud America 400
AF - Africa 73
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.790
Nazione #
US - Stati Uniti d'America 3.380
SG - Singapore 1.036
IT - Italia 511
IE - Irlanda 509
CN - Cina 330
BR - Brasile 309
HK - Hong Kong 302
UA - Ucraina 301
RU - Federazione Russa 299
SE - Svezia 245
VN - Vietnam 224
DE - Germania 183
FR - Francia 152
FI - Finlandia 134
GB - Regno Unito 99
KR - Corea 75
BD - Bangladesh 61
IN - India 51
CA - Canada 39
IQ - Iraq 31
TR - Turchia 31
AR - Argentina 30
AT - Austria 23
RO - Romania 23
PL - Polonia 22
JP - Giappone 20
MX - Messico 19
ZA - Sudafrica 18
NL - Olanda 16
CH - Svizzera 14
BE - Belgio 13
EC - Ecuador 13
ID - Indonesia 13
PK - Pakistan 12
VE - Venezuela 12
MA - Marocco 11
UZ - Uzbekistan 11
CO - Colombia 10
TN - Tunisia 10
BO - Bolivia 9
LB - Libano 9
ES - Italia 8
PH - Filippine 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
EG - Egitto 7
OM - Oman 7
CR - Costa Rica 6
GR - Grecia 6
KE - Kenya 6
PY - Paraguay 6
SN - Senegal 6
AL - Albania 5
AU - Australia 5
CL - Cile 5
JO - Giordania 5
ET - Etiopia 4
HN - Honduras 4
LT - Lituania 4
NP - Nepal 4
BA - Bosnia-Erzegovina 3
DZ - Algeria 3
IL - Israele 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EU - Europa 2
GT - Guatemala 2
TT - Trinidad e Tobago 2
BH - Bahrain 1
BS - Bahamas 1
CD - Congo 1
CM - Camerun 1
CV - Capo Verde 1
DJ - Gibuti 1
KG - Kirghizistan 1
KW - Kuwait 1
MK - Macedonia 1
MM - Myanmar 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 8.789
Città #
Singapore 708
Chandler 528
Dublin 509
Hong Kong 300
San Jose 286
San Mateo 210
Ashburn 185
Perugia 178
Jacksonville 156
Santa Clara 141
Boardman 140
Moscow 104
Medford 98
Princeton 98
Ann Arbor 97
Beijing 93
Lauterbourg 85
Andover 84
Dong Ket 75
Seoul 75
Wilmington 75
Munich 60
Altamura 59
Lawrence 58
Ho Chi Minh City 51
Los Angeles 51
New York 42
Helsinki 37
The Dalles 36
Des Moines 35
São Paulo 33
Hanoi 31
Houston 29
Dallas 27
Redwood City 27
Saint Petersburg 25
Bucharest 21
Norwalk 20
Woodbridge 20
Tokyo 19
Brooklyn 17
Frankfurt am Main 17
Piscataway 17
Chennai 16
Redmond 16
Rome 16
Turku 16
Falkenstein 15
Montreal 15
Nuremberg 15
Warsaw 15
Orem 14
Atlanta 13
Brussels 13
Milan 13
Coccaglio 12
Johannesburg 12
London 12
Mexico City 12
Phoenix 11
Poplar 11
San Mauro Pascoli 11
Stockholm 11
Caracas 10
Chicago 10
Izmir 10
Baghdad 9
Dearborn 9
Denver 9
San Paolo di Civitate 9
Terni 9
Vienna 9
Den Haag 8
Haiphong 8
Rio de Janeiro 8
Toronto 8
Council Bluffs 7
Guangzhou 7
Shanghai 7
Da Nang 6
Dakar 6
Dhaka 6
Falls Church 6
Istanbul 6
Manchester 6
Marsciano 6
New Delhi 6
Quito 6
Tashkent 6
Tunis 6
Amman 5
Amsterdam 5
Ankara 5
Bologna 5
Boston 5
Brasília 5
Curitiba 5
Erbil 5
Florence 5
Goiânia 5
Totale 5.479
Nome #
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications 193
An Application of Conditional Robust Calibration (CRC) to The Lotka-Volterra Predator-Prey model in computational systems biology: a comparison of two sampling strategies 174
Cancer Registry and information technology: a new management system for integrating Cancer Registry and Oncology Departments 156
I Tumori multipli in Umbria. 132
Prognostic Role of Erbb Family Receptors, Myc and Mitogen-activated Protein Kinase (mapk) In Patients With Early-stage Non Small-cell Lung Cancer 129
Gene identification for risk of relapse in stage I lung adenocarcinoma patients: A combined methodology of gene expression profiling and computational gene network analysis 129
Partecipazione al IV round dello screening citologico nella AUSL 2 dell’Umbria. 127
Significato prognostico dell’espressione immunoistochimica di Insulin like growth facor receptor 1 (IGFR-1) ed epidermal growth factor receptor (EGFR) nei carcinomi non a piccole cellule del polmone (NSCLC). 123
Incidence of multiple primary cancers following respiratory tract cancer in Umbria, Italy. 123
P-126 * PROGNOSTIC SIGNIFICANCE OF MYC AND HUMAN TELOMERASE GENE AMPLIFICATION IN SURGICALLY TREATED EARLY STAGE NON-SMALL CELL LUNG CANCER 121
A New Bayesian Methodology for Nonlinear Model Calibration in Computational Systems Biology 121
Cancer incidence in Italian contaminated sites 120
A machine learning approach applied to Reverse Phase Protein Microarray data for pathways activation mapping of KRAS wild type and mutated adenocarcinomas of the lung 118
A Hybrid Model of Nucleotide Excision Repair in Neoplastic Diseases: The Identification Problem. 117
Effectiveness and predictability of pleurodesis with the Tachosil® surgical patch compared with talc poudrage: An experimental study 117
Cancer burden trends in Umbria region using a joinpoint regression 113
MYC and Human Telomerase Gene (TERC) Copy Number Gain in Early-stage Non-small Cell Lung Cancer 110
Spatial barriers impact upon appropriate delivery of radiotherapy in breast cancer patients 110
Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer 108
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 108
A Hybrid Model of Nucleotide Excision Repair in Neoplastic diseases and in vitro Experiments 106
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations. 106
EPIDEMIOLOGIA DEL CANCRO DELL'ENDOMETRIO IN UMBRIA 104
Robust Calibration of High Dimension Nonlinear Dynamical Models for Omics Data: An Application in Cancer Systems Biology 104
Information technology as tools for Cancer Registry and Regional Cancer Network integration 103
Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcome in Resected Non-Small Cell Lung Cancer Patients 103
An approach for optimally extending mathematical models of signaling networks using omics data 103
Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients 101
I tumori della tiroide 99
I tumori dell'ovaio. 97
Effect of healthcare on mortality: trends in avoidable mortality in Umbria, Italy, 1994-2009 97
An approach to the conditional robustness problem for biochemical networks 97
Come misurare “l’impatto” dello screening colorettale nella Regione Umbria 96
Prognostic implication of aquaporin 1 overexpression in resected lung adenocarcinoma 96
Reverse phase protein array (RPPA) combined with computational analysis to unravel relevant prognostic factors in non- small cell lung cancer (NSCLC): a pilot study 96
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients 96
High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free servival in resected non-small-cell lung cancer patients. 95
Registro Tumori, tecnologia informatica e rete oncologica regionale. Integrazione tra Registro Tumori e Servizi oncologici in Umbria. 94
Espressione dei recettori HER nei carcinomi non a piccole cellule del polmone 94
Screening for colorectal cancer in Italy: 2011-2012 survey 93
Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC). 92
Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology 92
Regional indices of socio-economic and health inequalities: a tool for public health programming 92
A strategy for parameter estimation for mRNA and protein dynamics 91
I tumori del rene 90
Modelli dinamici per lo studio dei meccanismi di riparo del danno al DNA 89
High coexpression of both insulin-like growth factor receptor 1 (igfr-1) and epidermal growth factor receptor (egfr) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients 89
THE EVOLVING ROLE OF CANCER REGISTRY: INFORMATION TECHNOLOGY AS TOOL FOR INTEGRATION WITH ONCOLOGY DEPARTMENTS 87
EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients. 87
Cancer registry integration in the Umbria Regional Cancer Network: breast cancer as a model to build a supportive information system. 87
I tumori delle alte vie aero-digestive. 87
Linking surgical specimen length and examined lymph nodes in colorectal cancer patients 84
Prognostic implications of epidermal growth factor receptor, KRAS and BRAF gene mutations in resected non-small cell lung cancer patients 84
Numeri dell'AIRTUM: 2000 giovani italiani vivono con il cancro. 83
Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology (vol 30, pg 142, 2012) 83
Dynamic network topologies analysis in proteomics data of NSCLC cell lines using a new pipeline based on machine learning tools 83
Staging, missing prognostic information and colorectal cancer control in Umbria 82
La geografia del cancro in Umbria: incidenza 1978-2008. 82
Stadio alla diagnosi e controllo del cancro del grosso intestino in Umbria. 81
I tumori del pene e del testicolo. 81
Seasonality of birth for skin melanoma deserves further investigation 81
Geographical suite for web management system of cancer registries 80
Epidemiology of HPV-related female cancers in the Umbria region of Italy: Pre-vaccination period 80
Registro Tumori, tecnologia informatica e rete oncologica regionale: integrazione tra Registro Tumori e Servizi oncologici in Umbria. XIII Riunione annuale AIRTum. 78
Clinical significances of ErbB family receptors, Myc, and mitogen-activated protein kinase (MAPK) in patients with early-stage non-small cell lung cancer. 78
Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology 78
Use of Electronic Administrative Databases to Measure Quality Indicators of Breast Cancer Care: Experience of Five Regional Oncology Networks in Italy 78
Systems biology in personalized medicine in oncology: A case study in non-small cell lung cancer 77
Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. 77
Trend di incidenza e mortalità per cancro negli anziani in Umbria. 76
Prevalence and spectrum of brca germline variants in central Italian high risk or familial breast/ovarian cancer patients: A monocentric study 75
Narrative Medicine in Amyotrophic Lateral Sclerosis and a Rehabilitation Project Based on International Classification of Functioning, Disability and Health 74
I tumori della vescica. 74
Dynamic modeling and parameter identification for biological networks: application to the DNA damage and repair processes 73
Dynamic modeling, parameter estimation and experiment design in Systems Biology with applications to Oncology 72
Trends in invasive and in situ (CIN 3) cervical cancer incidence and mortality in Umbria, Italy: 1994-2008 72
Role of Expression Levels of Fabp3, H19, Tfpi2, Ark1b1 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients. 71
Cancer and Pregnancy: Estimates in Italy from Record-Linkage Procedures between Cancer Registries and the Hospital Discharge Database 68
Gruppo multidisciplinare regionale per le neoplasie tiroidee, registro tumori e tecnologia informatica: integrazione tra registro tumori e specialisti di oncologia tiroidea in Umbria. 67
I tumori in Italia, rapporto 2011. La sopravvivenza dei pazienti oncologici in Italia. 67
INSULIN-LIKE GROWTH FACTOR RECEPTOR 1 (IGF1R) AND EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFICATION AND EXPRESSION IN SURGICALLY RESECTED NSCLC 65
What has changed in the epidemiology of skin melanoma in central Italy during the past 20 years? 65
I numeri di AIRTUM: Buone notizie per i bambini italiani. Dopo il 2000 si arresta anche la crescita dei tumori maligni del sistema nervoso centrale. 64
Envelope stress response in E.Coli: computational model 63
Robustness of complex feedback systems: application to oncological biochemical networks 63
Seasonal variation in the month of birth in patients with skin cancer 63
Systems Biology and translational oncology: a case study of predictive modeling in molecular biology of the lung cancer 62
MYC and human telomerase (TERC) gene copy number gain in resected non-small cell lung cancer (NSCLC) 62
KRAS gene mutation testing an inter-laboratory validated workflow for quality assured, clinical-grade results using capillary electrophoresis. 61
SYSTEMS BIOLOGY IN TRANSLATIONAL ONCOLOGY: COMPUTATIONAL AND EXPERIMENTAL STUDY OF EGFR AND IGF1R PATHWAYS IN NSCLC CELL LINES 60
Trend di mortalità per cause in Umbria. 1994-2010 57
Assessment of TILs, IDO-1 and PD-L1 in resected non small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications. 56
Espressione dei recettori Her nei carcinomi non a piccole cellule del polmone. 56
Genome-wide expression of the residual lung reacting to experimental Pneumonectomy 56
Prognostic Role of Expression Levels of Fabp3, H19, Tfpi2, Akr1b10 Cyp3a5, Scgb3a2 Genes In Adenocarcinoma Stage I Patients 55
Prognostic role of expression levels of FABP3 and AKR1B10 genes in adenocarcinoma stage I patients. 52
Trend d’incidenza delle lesioni cervicali in situ ed infiltranti in Umbria. 51
Influence of geographic barriers and care pathways on radiotherapy treatment and survival of breast cancer patients 51
PROGNOSTIC AND PREDICTIVE ROLE OF PIK3CA MUTATIONS IN NON SMALL CELL LUNG CANCER PATIENTS TREATED WITH EGFR TYROSINE KINASE INHIBITORS (TKIS) 47
Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of MET, EGFR, KRAS, and PIK3CA mutations. 43
Totale 8.903
Categoria #
all - tutte 40.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022830 20 144 9 47 12 5 13 288 29 27 93 143
2022/20231.601 109 249 33 127 127 170 0 73 650 2 54 7
2023/2024600 35 54 27 23 4 5 151 26 66 16 107 86
2024/20251.279 33 121 106 34 157 62 41 99 235 72 207 112
2025/20262.974 211 190 159 412 440 248 462 142 299 271 99 41
2026/20275 5 0 0 0 0 0 0 0 0 0 0 0
Totale 9.007